CD96, which is mainly expressed in natural killer (NK) cells and T cells, acts as a vital checkpoint in immunity and tumor progression, with CD96 mice displaying hypersensitive NK-cell responses to immune challenge and significant tumor resistance (Blake et al., 2016). The gene discussed is CD96; the disease is neoplasm.